Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,397 public trials 2,851 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.

NCT00210743

Conditions: Anemia, Chronic Disease, Disease Attributes, +12 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

NCT00261677

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia

NCT00338299

Conditions: Anemia, Chemotherapy, Hematologic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia

NCT00790127

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Chronic Care Center Beirut, Lebanon

Siriraj Hospital Bangkok, Bangkoknoin District, Thailand

View Trial Details

Completed

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

NCT00315432

Conditions: Anemia, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: Not specified

View Trial Details

Completed

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

NCT00315484

Conditions: Anemia, Chemotherapy, Hematologic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

NCT00317902

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

NCT00216541

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT00844441

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations: Oregon Health and Science University Portland, Oregon, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland

View Trial Details

Completed

A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)

NCT00328549

Conditions: Anemia, Blood-Borne Infections, Communicable Diseases, +11 more
Locations: Not specified

View Trial Details